ArticleACS medicinal chemistry letters2016

Discovery and Preclinical Evaluation of BMS-711939, an Oxybenzylglycine Based PPARα Selective Agonist.

Yan Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.